Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

• Richard A. Hubner,

  Affiliation Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Richard D. Riley,

  Affiliation Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Lucinda J. Billingham,

  Affiliations Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom, MRC Midland Hub for Trials Methodology Research, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Sanjay Popat

  * E-mail: sanjay.popat@rmh.nhs.uk

  Affiliations Department of Medicine, Royal Marsden NHS Foundation Trust, London, United Kingdom, Molecular Genetics Group, Imperial College, London, United Kingdom

  ⨯